Plato Investment Management Ltd Purchases Shares of 6,919 HCA Healthcare, Inc. $HCA

Plato Investment Management Ltd acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,919 shares of the company’s stock, valued at approximately $2,682,000.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in HCA Healthcare during the fourth quarter valued at $374,037,000. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in HCA Healthcare by 5,941.1% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 381,433 shares of the company’s stock worth $180,509,000 after acquiring an additional 375,119 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $404.61 on Monday. The company’s 50-day simple moving average is $393.41 and its two-hundred day simple moving average is $446.61. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company has a market capitalization of $87.60 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.84 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HCA. Wells Fargo & Company raised their price objective on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Barclays dropped their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $465.59.

Check Out Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.